共 50 条
- [1] Structure-Based Drug Design of Novel, Potent, and Selective Azabenzimidazoles (ABI) as ATR Inhibitors[J]. ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (01): : 42 - 46Barsanti, Paul A.Pan, YueLu, YipinJain, RamaCox, MatthewAversa, Robert J.Dillon, Michael P.Ening, RobertHu, ChengJin, XianmingKnapp, MarkLan, JiongRamurthy, SavithriRudewicz, PatrickSetti, LinaSubramanian, SharadhaMathur, MichelleTaricani, LorenaThomas, GeorgeXiao, LindaYue, Qin
- [2] Development of Selective, Potent RabGGTase Inhibitors[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (19) : 8330 - 8340Stigter, E. AnoukGuo, ZhongBon, Robin S.Wu, Yao-WenChoidas, AxelWolf, AlexanderMenninger, SaschaWaldmann, HerbertBlankenfeldt, WulfGoody, Roger S.
- [3] THE DEVELOPMENT OF POTENT AND HIGHLY SELECTIVE THROMBIN INHIBITORS[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1995, 30 : S131 - S138HILPERT, KACKERMANN, JBANNER, DWGAST, AGUBERNATOR, KSCHMID, GTSCHOPP, TBVANDEWATERBEEMD, K
- [4] Development of potent and selective factor Xa inhibitors[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (14) : 1797 - 1800Rai, RKolesnikov, ALi, YYoung, WBLeahy, ESprengeler, PAVerner, EShrader, WDBurgess-Henry, JSangalang, JCAllen, DChen, XKatz, BALuong, CElrod, KCregar, L
- [5] ATR inhibitors synergize with DHFR inhibitors in rhabdomyosarcoma cells by disrupting DNA damage checkpoint[J]. CANCER RESEARCH, 2024, 84 (07)Jo, UkhyunAnnor, George K.Shern, Jack F.
- [6] Development of Potent and Highly Selective Epoxyketone-Based Plasmodium Proteasome Inhibitors[J]. CHEMISTRY-A EUROPEAN JOURNAL, 2023, 29 (20)Almaliti, JehadFajtova, PavlaCalla, JaesonLaMonte, Gregory M.Feng, MudongRocamora, FrancesOttilie, SabineGlukhov, EvgeniaBoura, EvzenSuhandynata, Raymond T.Momper, Jeremiah D.Gilson, Michael K.Winzeler, Elizabeth A.Gerwick, William H.O'Donoghue, Anthony J.
- [7] Aldehyde dehydrogenase inhibitors promote DNA damage in ovarian cancer and synergize with ATM/ATR inhibitors[J]. THERANOSTICS, 2021, 11 (08): : 3540 - 3551Grimley, EdwardCole, Alexander J.Luong, Thong T.McGonigal, Stacy C.Sinno, SarahYang, DongliBernstein, Kara A.Buckanovich, Ronald J.
- [8] Development of potent and selective factor Xa inhibitors.[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U9 - U9Rai, RKolesnikov, AYoung, WBSprengeler, PALeahy, EMLi, YShrader, WDBurgess-Henry, JSangalang, JVerner, EJAllen, DChen, XElrod, KCCregar, LKatz, BALuong, C
- [9] Design and development of potent and selective factor IXa inhibitors[J]. JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS, 2016, 68 : 130 - 135Choudhari, Prafulla B.Bhatia, Manish S.Jadhav, Swapnil D.Kumbhar, Santosh S.Ingale, Kundan B.Gaikwad, Vinod L.
- [10] Development of a novel class of potent and selective FIXa inhibitors[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (21) : 4945 - 4949Zhang, TingAndre, PatrickBateman, Thomas J.Chen, Yi-HengDesai, KunalEllsworth, KennethGeissler, Wayne M.Guo, LiangqinHruza, AlanJian, TianyingMeng, DongfangParker, Dann L., Jr.Qian, XiaoxiaReichert, PaulSherer, Edward C.Shu, MinSmith, Cameron J.Sonatore, Lisa M.Tschirret-Guth, RichardNolting, Andrew F.Orr, RobertCampeau, Louis-CharlesAraki, KazutoNishimura, TeruyukiSakurada, IsaoWood, Harold B.